Ford Financial Group, LLC Biomarin Pharmaceutical Inc Transaction History

Ford Financial Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 13, 2022	SELL	$74.28 - $92.69 $1,559 - $1,946	-21 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$71.72 - $91.47 $1,506 - $1,920	21 New	21 $1,000
Q3 2021 Nov 05, 2021	SELL	$74.77 - $85.47 $1,570 - $1,794	-21 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$75.51 - $84.79 $1,585 - $1,780	21 New	21 $1,000
Q1 2018 May 11, 2018	SELL	$77.67 - $92.63 $4,427 - $5,279	-57 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$80.76 - $95.13 $4,603 - $5,422	57	57 $5,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Ford Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Ford Financial Group, LLC with notifications on news.